Jones Financial Companies
VRTX icon

Jones Financial Companies’s Vertex Pharmaceuticals VRTX Stock Holding History

Jones Financial Companies’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$106M Buy
215,419
+12,559
+6% +$5.57M 0.04% 237
2026
Q1 		$87.9M Buy
202,860
+194,865
+2,437% +$90.9M 0.04% 221
2025
Q4 		$3.62M Buy
7,995
+871
+12% +$375K ﹤0.01% 748
2025
Q3 		$2.75M Buy
7,124
+1,108
+18% +$463K ﹤0.01% 765
2025
Q2 		$2.66M Buy
6,016
+2,035
+51% +$938K ﹤0.01% 683
2025
Q1 		$1.96M Buy
3,981
+1,513
+61% +$705K ﹤0.01% 658
2024
Q4 		$994K Buy
2,468
+1,062
+76% +$492K ﹤0.01% 749
2024
Q3 		$651K Buy
1,406
+808
+135% +$388K ﹤0.01% 728
2024
Q2 		$280K Buy
598
+583
+3,887% +$253K ﹤0.01% 727
2024
Q1 		$6.27K Buy
15
+9
+150% +$3.81K ﹤0.01% 1141
2023
Q4 		$2.44K Buy
+6
New +$2.22K ﹤0.01% 885
2023
Q1 		– Sell
-8
Closed -$2K – 786
2022
Q4 		$2K Buy
+8
New +$2.44K ﹤0.01% 622
2022
Q3 		– Sell
-4
Closed -$1K – 740
2022
Q2 		$1K Buy
+4
New +$1.07K ﹤0.01% 694
2022
Q1 		– Sell
-13
Closed -$3K – 848
2021
Q4 		$3K Hold
13
– – ﹤0.01% 705
2021
Q3 		$2K Hold
13
– – ﹤0.01% 627
2021
Q2 		$3K Sell
13
-16
-55% -$3.35K ﹤0.01% 600
2021
Q1 		$6K Sell
29
-104
-78% -$22.8K ﹤0.01% 607
2020
Q4 		$31K Buy
+133
New +$30.5K ﹤0.01% 332
2013
Q4 		– Sell
-26
Closed -$2K – 538
2013
Q3 		$2K Buy
+26
New +$2.07K ﹤0.01% 659

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Jones Financial Companies's VRTX Position: Q2 2026 in Review

Jones Financial Companies increased its Vertex Pharmaceuticals (VRTX) stake by 6.2% in Q2 2026, buying an estimated $5.57M and bringing the position to 215,419 shares worth $106M. The position accounts for 0.04% of the portfolio, ranked #237.

Jones Financial Companies first reported a position in VRTX in Q3 2013 and has held it in 19 quarters since. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Jones Financial Companies held 215,419 shares of Vertex Pharmaceuticals worth $106M as of Q2 2026.
  • Jones Financial Companies bought 12,559 Vertex Pharmaceuticals shares in Q2 2026, an estimated $5.57M.
  • Vertex Pharmaceuticals made up 0.04% of Jones Financial Companies's portfolio in Q2 2026, its #237 holding.
  • Jones Financial Companies first reported a position in Vertex Pharmaceuticals in Q3 2013 and has held it in 19 quarters since.
  • 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.